Novel radionuclides for use in Nuclear Medicine in Europe: where do we stand and where do we go?

Maija Radzina Laura Saule Edgars Mamis Ulli Koester Thomas Elias Cocolios Elina Pajuste Marika Kalnina Kristaps PalskisZoe SawitzkiZeynep Talip Mikael Jensen Charlotte DucheminKirsten LeufgenThierry Stora

Published in: EJNMMI radiopharmacy and chemistry (2023)

Thanks to a questionnaire distributed by the PRISMAP consortium, the current status and needs of clinical end-users in nuclear medicine were identified.

Keyphrases

current status
cross sectional
psychometric properties